JJHCS DePuy Synthes CMF and Trauma Procedural Packages
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Logistics Agency (DLA) Troop Support, Medical Supply Chain, is seeking to acquire Johnson & Johnson Health Care Systems (JJHCS) DePuy Synthes Cranial and Maxillofacial (CMF) and Trauma "procedural packages". This acquisition is being conducted under Other Than Full and Open Competition, citing "Only One Responsible Source" (FAR 6.302-1(a)(2) and (c)). The solicitation is available on the DLA Internet Bid Board System (DIBBS). Responses are due June 11, 2026.
Scope of Work
This opportunity involves the procurement of JJHCS DePuy Synthes CMF and Trauma procedural packages, which include essential implants, trauma products, instrumentation sets, and auxiliary products for orthopedic surgery. Delivery methods will include Just-in-Time (JIT), Direct Vendor Delivery (DVD), or Consignment. A critical requirement is the provision of on-site technical support from a qualified JJHCS DePuy Synthes representative.
Contract & Timeline
- Contract Type: Fixed Price with Economic Price Adjustment (EPA), Indefinite Delivery/Indefinite Quantity (IDIQ)
- Duration: Five (5) years
- Estimated Value: Approximately $208,336,345.00 (estimated) with a maximum potential value of $416,672,690.00 over the five-year period.
- Response Date: June 11, 2026, 7:00 PM ET
- Published Date: April 27, 2026, 7:21 PM ET
- Place of Performance: Philadelphia, PA, United States
Set-Aside
This acquisition is justified for Other Than Full and Open Competition due to the unique and proprietary nature of DePuy Synthes products, which require specialized physician training for optimal patient outcomes. Market research, including a Sources Sought Notice, indicated that JJHCS DePuy Synthes was the only company capable of providing the complete required package.
Evaluation
The contracting officer determined that anticipated prices will be fair and reasonable based on commercial pricing. The justification highlights the critical need for brand-specific procurement to ensure continuity of care and patient safety.
Additional Notes
The Manufacturer Direct Program aims to establish an automated e-commerce solution for ordering these specialized procedural packages. The redacted Justification and Authorization (J&A) document is attached to the opportunity.